Prague medical experts arrive in Gujarat
Prague-based Zentiva Group continues its global expansion with the acquisition of a manufacturing site in Ankleshwar, Gujarat, serving people with its medicines.
Ankleshwar increases the number of wholly-owned Zentiva production sites worldwide, said Zentiva on 1 June 2020.
“We are continuing to deliver strong growth at Zentiva and the completion of this acquisition is an important milestone for our company,” Zentiva CEO Nick Haggar said.
“The strength of our growing manufacturing network and additional capacity means we can keep pace with the accelerating demand for our medicines and increase our direct control over our supply chain to help ensure a continuous supply and rapid response to patient needs.”
The transaction continues the flow of decisive growth moves made by Zentiva, building on earlier acquisitions of Creo Pharma in the UK, Solacium in Romania and the Central and Eastern European operations of Alvogen completed in April 2020.
This latest acquisition in India runs in parallel to the ongoing multiple multi-million Euro investments at Zentiva’s flagship sites in Prague and Bucharest.
“I am so proud that our Ankleshwar team will be part of an even stronger Zentiva, integrated into the organization’s long-term growth strategy,” added Ashwani Sood, Head of the Ankleshwar site.
“We know the demand for high quality and affordable medicines is increasing and we look forward to contributing to Zentiva’s success on this journey.”
The manufacturing site will be supported by a brand new Zentiva India affiliate office in Mumbai.
Zentiva is a producer of high-quality affordable medicines serving patients in Europe and beyond. fiinews.com
